Residue-to-Asset Diagnostics

Mottainai 5.0

A 2-day executive feasibility diagnostic to determine whether your residue streams can be converted in situ into engineered products that displace current purchases—turning residue liabilities into balance sheet assets.

Implementation

Joint-Venture

What this is

Identify and mitigate the Double-Spend.

Most organizations pay twice for materials: once to buy inputs, and again to remove the residues they generate. This Diagnostic provides a decision-grade feasibility package concluding with one recommendation: Proceed, Pause, or No-Go—with reasons, quantified ranges, and the minimum conditions required to change the decision.

Who it is for

We work exclusively with agro-businesses and industrial enterprises.

Operators who have

  • meaningful, recurring organic, fibrous, polymer-based, or similar residue streams (volume + continuity),

  • a plausible internal-use displacement opportunity (pallets, crates, boards, rigid parts, logistics components, and many more),

  • decision makers who want an economically grounded path to in-situ conversion.

What you receive

Deliverables

  • Residue Asset Map
    Streams, volumes (ranges), variability, contamination, handling/storage constraints.

  • Value Case (ranges with assumptions)
    Cost avoidance and input displacement potential; key sensitivity drivers.

  • Solution Selection
    Fit to ReMatter™ model (Agro / Pack / Tex) + recommended Cell class (throughput, footprint, utilities, staffing concept).

  • Risk & Compliance Snapshot
    Feedstock, operational and permitting considerations; critical unknowns to resolve.

  • 90-Day Roadmap
    Phased plan and gates from feasibility to pilot/engineering and commissioning.

How it works

Engagement

  • Remote Preparation

    Document review & preparation call

  • Onsite
    2 working days (walkthrough, interviews, residue verification, executive readout)

  • Final Diagnostics Report & Executive Recommendation

    Delivered within 10 business days after onsite (or after receipt of required data).

Investment

Terms

  • Investment
    EUR 8,000 fixed fee (Executive Diagnostics)

  • Travel
    Billed at cost, pre-approved (airfare, local transport, lodging)

  • Terms
    70% upfront, 30% due before release of the final report

  • Decision Integrity

    If the loop conditions, end-of-life logic, or economics do not meet minimum feasibility thresholds, the Diagnostic will conclude with a No-Go recommendation and specify what must change to move to Proceed.

Apply for the Diagnostics assessment, request the Residue Intake Form, and schedule the pre-call.

Access

Mandates are selectively accepted.

NATURE2WORLD serves as the industrial platform through which technology initiatives, joint ventures, and manufacturing ventures are developed alongside advisory mandates.

© NATURE2WORLD All Rights Reserved.